❌

Reading view

There are new articles available, click to refresh the page.

Experts credit smooth midterms to election workers, Democratic rout

An election worker feeds ballots into a verification and sorting machine at the Salt Lake County Government Center on Tuesday, June 23, 2026. (Photo by Marco Lozzi for Utah News Dispatch)

An election worker feeds ballots into a verification and sorting machine at the Salt Lake County Government Center on Tuesday, June 23, 2026. (Photo by Marco Lozzi for Utah News Dispatch)

After President Donald Trump’s aggressive push for control over elections, this month’s midterms went smoothly because of the resilience of state and local officials and Democrats’ sweeping victories, several election experts said Monday.

Nearly two weeks after Election Day, a panel of researchers and former local government officials expressed relief that the election system held. But panelists at the discussion, hosted virtually by the Safeguarding Democracy Project at the University of California, Los Angeles, also warned against complacency about future contests.

“It didn’t happen magically,” said Bill Gates, executive director of Arizona State University’s Mechanics of Democracy Laboratory, which supports efforts to combat election misinformation.

Election officials and voting rights advocates had braced for a chaotic aftermath to the election, including potential federal interference in voting. Election workers across the country gameplanned how they would react if federal agents showed up at the polls or tried to disrupt vote counting.

But on Election Day, no major incidents occurred and voting proceeded without federal interference. Gates and others credited election workers, saying their preparation — including for the possibility of disruption — ultimately helped ensure smooth voting.

“They were really concerned about federal intervention. It was their top concern at every single one of our events in the last year,” said Tammy Patrick, chief programs officer at Election Center, an operation of the National Association of Election Officials.

Trump toyed with meddling

The U.S. Constitution assigns states the responsibility of administering federal elections. Congress may override state election regulations, but the president has no unilateral authority over how elections are run.

Despite that, Trump made repeated attempts to assert such authority, including by signing executive orders attempting to impose a federal proof of citizenship requirement to vote and directing the U.S. Postal Service to impose restrictions on ballots sent through the mail.

Major portions of both orders have been blocked by federal courts. The U.S. Supreme Court halted the mail-ballot restrictions for the midterms, but their legality for the 2028 election remains unsettled.

Charles Stewart III, a professor of political science at the Massachusetts Institute of Technology, said the federal government was often “feckless” in its efforts to bend the election system. The decentralized nature of the electoral system — where states run their elections — also helped protect it, he said, against a “federal government that lacked the capacity to do a lot of things folks were worried about.”

The Trump administration launched an array of legal challenges in the leadup to the election. For months, the U.S. Department of Justice pursued dozens of lawsuits seeking sensitive voter data from states, though none have been successful.

Weeks before Election Day, the DOJ sued California to force the state to set aside ballots from suspected noncitizen voters. It also preemptively sued Alaska over the certification of its U.S. Senate race, and demanded ballots be set aside in Washington state. 

Federal judges blocked the legal challenges in California and Alaska, and a judge prohibited the DOJ from forcing election officials to segregate ballots in Washington state.

Guy-Uriel Charles, a professor of law at Harvard Law School, said that in many ways, the pre-election litigation was a good development.

“Instead of going and putting troops or agents at the polls … the Trump administration litigated their disputes,” Charles said.

Blue wave swept out challenges

As the results were counted, the broad nature of the Democrats’ wins tamped down on the possibility of a chaotic post-election period, the panelists said. At least at the national level, very few high-profile contests were extremely close, leaving less room for legal fights or claims of fraud.

The wide margins allowed news organizations to call enough races that it became clear within hours of the first polls closing that Democrats would take control of Congress. That meant that the few exceptionally close races, like the Senate races in Alaska and Mississippi, didn’t determine which party controls the chamber — reducing scrutiny of the elections in those states.

But if control of the Senate had hinged on Mississippi, the tight election in that state could have spiraled into a national controversy, some of the panelists indicated. 

Democrat Scott Colom led Republican Sen. Cindy Hyde-Smith by only a few dozen votes on election night. The Associated Press didn’t call the race for Colom until more than a week later, when he had a lead of 4,669 votes, or about 0.5 percentage points.

The state has no recount law, meaning that any recount would only occur if ordered by a court. Election officials also used data from the credit agency Experian to list voters as inactive, which required them to sign affidavits when they voted.

Rick Hasen, director of the Safeguarding Democracy Project and the moderator of the panel discussion, said that if Mississippi had decided control of the Senate and the national press had descended on the state and seen its election administration problems, “We would be in big trouble.”

Mississippi Secretary of State Michael Watson, a Republican, has defended the affidavit system. In an opinion column posted to his official website on Monday, Watson wrote that approximately 75% of affidavits were approved and counted.

Charles said the midterms reflected an electorate that wanted to send a “very clear message.” But he cautioned that the message may not always be so clear.

“We can’t count on that next time around, and I think there’s some warnings here that we must heed,” Charles said, “notwithstanding the great work by a number of people trying to assure that this election went as smoothly as possible.”

False birth control claims are proliferating, survey says

More than half of women of reproductive age have seen or heard the false claim that hormones in contraceptives are harmful, according to a new KFF survey. (Photo by Kelcie Moseley-Morris/Stateline)

More than half of women of reproductive age have seen or heard the false claim that hormones in contraceptives are harmful, according to a new KFF survey. (Photo by Kelcie Moseley-Morris/Stateline)

More than half of women of reproductive age have seen or heard the false claim that hormones in contraceptives are harmful, and about 4 in 10 have been exposed to the false idea that hormones in contraceptives limit your ability to get pregnant in the future, according to a new survey.

The survey by KFF, a nonprofit health research organization, also found that about a third of women between the ages of 18 and 49 have seen or heard the inaccurate assertion that natural family planning methods are just as effective as hormonal birth control, and a similar percentage have been exposed to the erroneous idea that emergency contraceptive pills cause abortions.

According to the American College of Obstetricians & Gynecologists, long-acting reversible contraception and hormonal birth control are much more effective at preventing pregnancy than fertility awareness-based methods such as menstrual cycle tracking.

A large majority of reproductive age women said health care providers are their most trusted source for reliable health care information, with 85% saying they trust them a great deal or a fair amount. In contrast, only 26% said they trust U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. for reliable health information, and 48% said they trust federal health agencies. About 25% said they trust AI tools and chatbots, and 14% said they trust  social media and social media influencers.

Kennedy has made several statements related to reproductive and sexual health that contradict the medical consensus, including that prenatal exposure to Tylenol and COVID vaccines may be linked to autism. Under Kennedy, HHS has shifted the focus of federal family planning and pregnancy prevention grants away from expanding contraceptive services and toward promoting childbearing or what’s known as restorative reproductive medicine.

The KFF survey found that among 3,538 women of reproductive age, about 35% said they saw or heard something about contraception on social media in the past 12 months.

Of those who saw social media posts about contraception, 78% said they had used contraception in the past 12 months, with 62% using hormonal methods. Of those, 8% stopped and 9% started a new method because of something they saw or heard on social media.

But for a larger share of this group, contraception-related posts led to further consultation, either with a doctor (19%) or online or from AI (36%). Women ages 18 to 25 were more likely to consult AI or the internet (46%) compared with women ages 36 to 49 (29%).

Stateline reporter Sofia Resnick can be reached at sresnick@stateline.org.

This story was originally produced by Stateline, which is part of States Newsroom, a nonprofit news network which includes Wisconsin Examiner, and is supported by grants and a coalition of donors as a 501c(3) public charity.

Misinformation, hesitancy could blunt impact of new cancer vaccines

Chase Johnson of Cary, North Carolina, is among the cancer survivors and patients participating in a clinical trial for a new breast cancer vaccine. New cancer vaccines could be coming, but doctors and researchers are worried that rising vaccine hesitancy, fueled in part by the Trump administration, could blunt their impact. (Photo courtesy of Chase Johnson)

Chase Johnson of Cary, North Carolina, is among the cancer survivors and patients participating in a clinical trial for a new breast cancer vaccine. New cancer vaccines could be coming, but doctors and researchers are worried that rising vaccine hesitancy, fueled in part by the Trump administration, could blunt their impact. (Photo courtesy of Chase Johnson)

Nearly five years ago, Chase Johnson was cured of breast cancer — but not of the profound anxiety that it would return.

When Johnson was originally diagnosed in 2021, the resident of Cary, North Carolina, was only 31 — nearly a decade away from the age at which regular mammograms are recommended — and she had no history of breast cancer in her family. She only got screened because her dog, Cato, kept poking her chest with his nose, which helped her discover a lump.

Doctors discovered that Johnson had stage 2B triple-negative breast cancer, a rare and aggressive form. They treated her with chemotherapy, radiation, and surgery, and in 2022, they declared her cancer free. Her oncologist warned her, however, that there was a 40% chance the cancer would return.

Anxious about that prospect, Johnson enrolled in a clinical trial at the Cleveland Clinic testing a new breast cancer vaccine, developed in partnership with Anixa Biosciences. That vaccine has shown positive early results: In nearly three-quarters of the participants, including Johnson, it has generated an immune response.

“It’s just so promising and as a patient, it gave me a lot of hope,” said Johnson, now 37. “I feel much more protected having done it.”

In the past two decades, there has been steady progress in developing vaccines for cancer. The vaccine Johnson is taking isn’t one of them, but researchers are especially excited about the potential of mRNA vaccines, which use synthetic genetic instructions to teach a person’s immune system how to recognize and destroy unique proteins found on cancer cells.

Just last month, pharmaceutical companies Moderna and Merck announced that a personalized mRNA cancer vaccine, combined with an immunotherapy drug, had succeeded in a late-stage trial for skin cancer. The news raised hopes that a wave of new cancer vaccines could be just over the horizon.

But will Americans be willing to take them?

Many doctors and researchers are concerned that vaccine misinformation — amplified by the Trump administration — and the resulting increase in vaccine hesitancy could blunt the impact of the new vaccines. In particular, they cite the false claim, which originated with mRNA COVID vaccines, that mRNA vaccines can super-charge tumors, creating so-called turbo cancer. 

Many point to the human papillomavirus (HPV) vaccine as a cautionary tale.

Some strains of HPV, which is spread through sexual contact, can cause cancer of the cervix, vagina, vulva, penis, anus, mouth, throat, head or neck. In 2006, the U.S. Food and Drug Administration approved an HPV vaccine for girls and women ages 9 to 26, and three years later the agency expanded approval to include boys and young men. Ideally, vaccination should occur before a person is sexually active.

The HPV vaccine is safe and extremely effective. But decades of misinformation, some of it spread by state and federal lawmakers, has reduced uptake: For four years in a row, vaccination rates for teenagers have not budged, and there is wide variation among states.

“I don’t think we can overstate the impact that the pandemic and the misinformation and disinformation around vaccines has had on all vaccines, including HPV vaccine,” said Dannell Boatman, an assistant professor at the West Virginia University Cancer Institute.

A 2024 study Boatman co-authored, funded by Merck, found that the HPV misinformation on social media platforms was most pervasive in the users’ comments.

“There were some really wild conspiracy theories about girls in India being killed with the HPV vaccine,” Boatman said. “We also were able to identify a lot of mistrust of authority.”

Boatman said she expects a similar dynamic with breast cancer vaccines, especially since some people already are spreading misinformation that mammograms can cause cancer. But she hopes an ongoing study on “inoculation theory” will help researchers combat false claims.

“Basically, you forewarn someone that they’re going to be exposed to misinformation,” she said, “and then you refute it or provide them just a little bit of evidence about why it doesn’t work.”

History of lawsuits

Before he joined the Trump administration, U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. filed complaints and lawsuits against Merck, the maker of the HPV vaccine, and claimed on social media that the “vaccine appears to be increasing the risk of cervical cancer in vaccinated age groups just as COVID vaccines raise the risk of COVID.”

Early in his tenure, Kennedy dismissed all 17 members of the HHS vaccine advisory panel, replacing some of them with vaccine skeptics. Under his leadership, HHS also has altered the child vaccine schedule for certain diseases, including HPV. So far, those changes have been blocked in federal court.

HHS did not respond to a Stateline request for comment.

Last month, after signing an executive order separating the measles, mumps and rubella (MMR) vaccine into three separate shots, Republican President Donald Trump suggested, falsely, that each individual vaccine could fill a “bottle of soda.” The administration has also proposed cutting funding for vaccine research and studies on vaccine hesitancy.

Epidemiologist Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, said Kennedy’s appointment spurred the creation of the Vaccine Integrity Project, a partnership between the center and the American Medical Association that tries to bolster public trust in vaccines. The project has published evidence reviews of some of the vaccines criticized by the Trump administration.

“To a young parent today who wants to do the right thing, they want to protect their child, they’re so confused because they hear from the leaders in public health in their government talk about these vaccines killing people,” Osterholm said.

“The credibility of 80 years of public health work of vaccines in this country is threatened because of confusion.”

In May, the center published an evidence review showing that HPV vaccines are not associated with serious side effects and reduce the risk of cervical cancer by 80% in individuals who are vaccinated by age 16, and by 66% in people vaccinated after 16.

Resistance from state lawmakers 

But the HPV vaccine has long faced resistance from some conservative lawmakers, who associate it with teen sex.

Last year, 78% of U.S. teenagers ages 13-17 had received at least one dose of the HPV vaccine and 63% had completed the full HPV vaccination series. But in some conservative-leaning states, the rates were much lower: The complete vaccination rate in Mississippi was only 31%. Oklahoma (46%), Kentucky (50%), Arkansas (52%) and South Carolina (55%) also had particularly low rates.

At the other end of the spectrum were Rhode Island (85%), Hawaii (82%) and Massachusetts (80%).

Some states, including Alabama and Oregon, have made recent efforts to boost their  HPV vaccine rates.

But other states, including Iowa, have enacted laws limiting access to the HPV vaccine.  Republican Gov. Kim Reynolds in May signed a law prohibiting Iowans under 18 from consenting to vaccinations related to sexually transmitted diseases and infections, including HPV.

Idaho Democratic state Rep. Brooke Green said anti-vaccine sentiment is increasing among residents of her state — and among her legislative colleagues. As a survivor of breast cancer, Green is excited about the prospect of new cancer vaccines, but she fears that rising hesitancy could be hurdle to widespread adoption.

She noted that Idaho Republicans introduced a bill this year that would have established a two-year moratorium on mRNA immunizations for children and pregnant women. Similar bills were introduced in at least a dozen other states, though none were enacted.

This year, lawmakers in 34 states introduced 209 bills seeking to loosen vaccination rules, limit access to certain kinds of vaccines or sow doubt about their safety, according to a recent analysis by The New York Times.

“We are seeing several attempts to address some of the scientific tools that are used to create vaccines, mRNA vaccines and so forth,” Green said. “As a cancer patient, these are life-saving tools that are helping us.”

“I’m thrilled to see these new innovative advancements in medicine for these vaccines. Now, is it going to be widely accepted?” said Green, who was first diagnosed with breast cancer in 2024, a week before her mother was diagnosed with the same cancer.

“There will be some hesitation and some pushback. But look at the flip side: ‘Do you want breast cancer or do you not? Do you want skin cancer? Do you not?’”

Chase Johnson, meanwhile, said her anxiety has significantly decreased, especially after celebrating five years in remission this summer.

“I think I’ll always have some sort of low-grade anxiety about it,” Johnson said. “But it’s definitely at a much lower level than it was before vaccination. It’s given me a great, great amount of peace of mind.”

Stateline reporter Sofia Resnick can be reached at sresnick@stateline.org.

This story was originally produced by Stateline, which is part of States Newsroom, a nonprofit news network which includes Wisconsin Examiner, and is supported by grants and a coalition of donors as a 501c(3) public charity.

❌